Skip to main content Skip to section navigation Skip to footer

Investors & Media

News & Events

Recent NewsView All News

Oct 14, 2026 8:05 am EDT

Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration

Sep 30, 2026 8:05 am EDT

Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration

Latest Presentation View All Presentations

Investor Presentation thumbnail

Nov 12, 2024

Investor Presentation

H.C. Wainwright 26th Annual Global Investment Conference thumbnail

Sep 9, 2024

H.C. Wainwright 26th Annual Global Investment Conference

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings